在同一捐赠者血造干细胞移植后,活体捐赠者肺移植:值得冒的风险
Stefania Camagni1, Lorenzo D'Antiga2, Fabiano Di Marco3
1Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.
Chest
|April 10, 2024
概括
活体供体肺移植 (LD LT) 提供了独特的优势,特别是在儿科病例中. 一个父子单叶移植在早期免疫抑制撤销方面取得了成功,这表明捐赠者的奇默可能会诱导耐受性.
科学领域:
- 医学 医学 医学 医学 医学
- 移植手术 移植手术
- 儿科肺病学 儿科肺病学
背景情况:
- 活体供体肺移植 (LD LT) 在西方国家很少见,但可以解决器官短缺问题.
- 它在特定的儿科病例中具有独特的优势.
- 由于先前的干细胞移植引起的并发症,需要采用这种方法.
研究的目的:
- 报告一个成功的父子单叶活体供体肺移植 (LD LT).
- 调查捐赠者奇默主义在实现移植耐受性方面的作用.
- 评估降低免疫抑制在儿科LDLT的可行性.
主要方法:
- 从一个活着的亲属捐赠者 (父亲) 到一个孩子的单叶肺移植.
- 初始低剂量免疫抑制疗法与早期停止.
- 监测完整的捐赠者混沌作为一个潜在的耐受机制.
主要成果:
- 成功的单叶LDLT,获得了良好的接受者和捐赠者的结果.
- 患者在移植后10个月表现出良好的肺功能.
- 实现了免疫抑制治疗的早期停止.
结论:
- 活体供体肺移植,即使是单叶,在特定的儿科情景中也是一个可行的选择.
- 完整的捐赠者嵌合体可能有助于移植耐受性,允许免疫抑制撤销.
- 仔细的外科规划和专业知识对于成功的儿科LDLT至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
327
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
327
Tissue Transplantation
360
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
360


